Seeking Alpha · VERA · October 22, 2026

Vera Therapeutics, Inc. (VERA) Discusses Final Efficacy Results of ORIGIN Phase III Trial of Atacicept in IgA Nephropathy Transcript

Get the app for more

Explore stock news, insights and company research.